Position in IDXX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$5,106,468
-$343,865 QoQ
Shares Held
9,700
0.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
4.03%
of 13F equity value
Holder Rank
#374
of 1,286 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PERKINS CAPITAL MANAGEMENT INC holds $26,693,573 across 9 Diagnostics & Research names. IDXX ranks #2 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
40,605 | $11,022,227 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
This page
|
9,700 | $5,106,468 | |
| 3 | VCYT |
Veracyte, Inc.
|
59,958 | $3,521,333 | |
| 4 | PSNL |
Personalis, Inc.
|
239,000 | $3,202,600 | |
| 5 | NEO |
Neogenomics Inc
|
110,040 | $1,605,483 | |
| 6 | BDSX |
Biodesix Inc
|
44,618 | $1,006,135 | |
| 7 | MDXH |
MDxHealth SA
|
1,411,891 | $580,287 | |
| 8 | CSTL |
Castle Biosciences Inc
|
16,140 | $384,939 |
All Filings in IDXX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,106,468 | 9,700 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $5,450,333 | 9,700 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $6,562,341 | 9,700 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $6,197,233 | 9,700 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $5,202,498 | 9,700 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,073,515 | 9,700 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $4,010,368 | 9,700 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,900,634 | 9,700 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $5,115,600 | 10,500 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,669,265 | 10,500 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,828,025 | 10,500 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $4,724,702 | 10,805 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $5,426,595 | 10,805 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $5,403,364 | 10,805 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $4,408,007 | 10,805 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $3,520,269 | 10,805 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $3,789,637 | 10,805 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $5,910,983 | 10,805 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $7,114,660 | 10,805 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,906,199 | 11,105 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $7,013,362 | 11,105 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $5,433,787 | 11,105 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $5,551,056 | 11,105 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $4,404,797 | 11,205 | Shares | Sole | 2020-10-28 | |
| 2020-03-31 | $2,714,299 | 11,205 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||